Meeting Objectives:
-
-
Review the prevalence, clinical and economic burden, and patient outcomes associated with HFpEF and HFmrEF, and consider how these phenotypes compare with HFrEF in shaping perceptions of disease severity and management priorities.
-
Examine current guideline-recommended management strategies, emerging therapeutic options, and ongoing challenges in the care of patients with HFpEF and HFmrEF, including considerations related to therapy selection, medication access, and transitions of care.
-
Discuss the role of clinical pharmacists within multidisciplinary care teams and structured care pathways to support earlier identification, treatment initiation, and ongoing management of patients with HFpEF and HFmrEF.
-
Share This Event